PR Newswire SHANGHAI, Aug. 19, 2024 SHANGHAI, Aug. 19, 2024 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and ...
PR Newswire HANGZHOU, China, Aug. 15, 2024 HANGZHOU, China, Aug. 15, 2024 /PRNewswire/ -- Vimgreen Pharmaceuticals, a science-driven pharmaceutical company focused on the modulation of adenosine signaling, announced today the completion of ...
PR Newswire AUSTIN, Texas, Aug. 15, 2024 Chief Medical Officer Provides Overview of Recent Positive Clinical Patient Outcomes Video Highlights Recent Oncology Clinical Development Program Updates AUSTIN, Texas, Aug. 15, 2024 ...
PR Newswire BOSTON, Aug. 13, 2024 - SION-719 and SION-451 are candidates from Sionna's next generation series of highly potent NBD1 stabilizers - BOSTON, Aug. 13, 2024 /PRNewswire/ -- Sionna Therapeutics, a clinical-stage life sciences ...
TÜBINGEN, Germany , Aug. 12, 2024 /PRNewswire/ -- Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR ...
77.6% of patients treated with palopegteriparatide in the PaTHway China Trial achieved the primary multi-component endpoint compared to 0.0% for placebo (p <0.0001) Palopegteriparatide was generally safe and well-tolerated, ...
SAN DIEGO , Aug. 8, 2024 /PRNewswire/ -- Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for their Phase 1 clinical trial of AGX101, a ...
Summary T-Maximum Pharmaceutical develops allogeneic CAR-T therapies with a unique CRISPR/Cas9 Gene-Editing platform for solid tumors, provide a solution of two major pain points, GvHD and HvG, aiming to revolutionize cancer. MT027, the ...
The groundbreaking pure C15:0 supplement from Seraphina Therapeutics raises C15:0 levels and supports liver and red blood cell health in independently run clinical trial at the University of California, San Diego SAN DIEGO , Aug. 6, ...
Raising dietary intake and circulating levels of C15:0, an essential fatty acid, improved liver health among young adults with overweight and obesity. SAN DIEGO , Aug. 6, 2024 /PRNewswire-PRWeb/ -- A highly anticipated clinical trial ...
Vanderbilt’s Phase I trial of VU319 demonstrates promising results for Alzheimer’s and schizophrenia
Late-breaking research finds no survival benefit from autologous stem cell transplant in mantle cell lymphoma patients with undetectable MRD.
Hypovolemic phlebotomy, removing 10% of blood before liver surgery, can cut transfusion needs by 50%, offering a safe, cost-effective way to reduce surgery risks.
Felzartamab, an investigational antibody, reduces triggers linked to IgA nephropathy, an autoimmune kidney disease, suggesting lasting clinical benefits.
Discover how FarrSight ®-Twin technology utilizes digital twins to revolutionize cancer clinical trials by simulating patient responses.
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers